D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 6.40M 8.22M 8.37M 7.83M 15.74M
Total Other Revenue -- -- -- -- --
Total Revenue 6.40M 8.22M 8.37M 7.83M 15.74M
Cost of Revenue 72.40M 70.49M 64.27M 59.93M 60.20M
Gross Profit -66.00M -62.28M -55.91M -52.10M -44.46M
SG&A Expenses 24.41M 23.24M 22.58M 21.97M 21.35M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 96.81M 93.73M 86.85M 81.90M 81.55M
Operating Income -90.41M -85.51M -78.48M -74.08M -65.81M
Income Before Tax -79.63M -75.74M -69.66M -64.92M -141.68M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -79.63 -75.74 -69.66 -64.92 -141.68
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -79.63M -75.74M -69.66M -64.92M -141.68M
EBIT -90.41M -85.51M -78.48M -74.08M -65.81M
EBITDA -68.45M -85.49M -78.43M -74.00M -65.70M
EPS Basic -0.59 -0.59 -0.56 -0.53 -1.38
Normalized Basic EPS -0.37 -0.36 -0.34 -0.32 -0.29
EPS Diluted -0.59 -0.59 -0.56 -0.53 -1.38
Normalized Diluted EPS -0.37 -0.36 -0.34 -0.32 -0.29
Average Basic Shares Outstanding 543.66M 516.83M 496.68M 490.26M 462.90M
Average Diluted Shares Outstanding 543.66M 516.83M 496.68M 490.26M 462.90M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --